Clinical Trials Directory

Trials / Terminated

TerminatedNCT01540669

Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time

Dose-ranging Efficacy of 2-week Polydextrose Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebocontrolled Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Danisco · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to test the effect of polydextrose on whole gut transit time and gastrointestinal symptoms in a dose-responsive manner.

Detailed description

Given the promising, yet largely unsubstantiated, benefits of fiber supplementation, particularly polydextrose, on symptoms of functional constipation, the objective of this clinical trial is to evaluate the safety and effectiveness of 2-week supplementation of a proprietary polydextrose fiber product, in a dose-ranging fashion, on whole gut transit time and gastrointestinal symptoms in adults with functional constipation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolydextrose, low dose4g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks
DIETARY_SUPPLEMENTPolydextrose, medium dose8g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks
DIETARY_SUPPLEMENTPolydextrose, high dose12g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks
DIETARY_SUPPLEMENTPlacebo powderPlacebo powder will be mixed with beverage and consumed once per day for 2 weeks

Timeline

Start date
2012-03-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2012-02-29
Last updated
2016-01-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01540669. Inclusion in this directory is not an endorsement.